ClinicalTrials.Veeva

Menu

Biological Monitoring of Nano Sized Particles in the Airways of Asthmatic Children (EHF)

T

Tel Aviv Sourasky Medical Center

Status

Unknown

Conditions

Asthma

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Background Ambient airborne particulate material (PM) is defined according the aerodynamic diameter into coarse, fine, and ultrafine or "nano" sized particles ranging between 2.5-10 µm (coarse), <2.5 µm (fine), and <0.1 µm (nano(. Many studies have examined particle effect on respiratory health in children, mainly by environmental monitoring of coarse and fine particles. Biological assessment of individual exposure to nano sized particles in correlation to adverse health effect was not previously studied.

Hypothesis individual exposure to nano sized particles in children is associated with reduction in forced expiratory volume at one second.

Enrollment

100 estimated patients

Sex

All

Ages

6 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age 6-18 years
  • living in the Tel Aviv area
  • referred to the pulmonology lab for respiratory function evaluation

Exclusion criteria

  • Exposure to cigarette smoke
  • Respiratory infection in the 4 weeks prior to recruitment and testing

Trial contacts and locations

1

Loading...

Central trial contact

Elizabeth Fireman, Phd; Shira Benor, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems